[ON THE THERAPY OF DIABETES MELLITUS WITH 2-BENZENESULFONAMIDO-5-(2-METHOXYETHOXY)-PYRIMIDINE (GLYCODIAZIN). EXPERIENCES WITH 160 DIABETICS].
D035843:Biomedical Research; D003920:Diabetes Mellitus; D004358:Drug Therapy; D004361:Drug Tolerance; D007004:Hypoglycemic Agents; D008099:Liver; D010336:Pathology; D011743:Pyrimidines; D013449:Sulfonamides; D014044:Tolbutamide; D014116:Toxicology
D007004:Hypoglycemic Agents; D011743:Pyrimidines; D013449:Sulfonamides; D014044:Tolbutamide; C030986:pyrimidine
ANTIDIABETICS; CLINICAL RESEARCH; DRUG THERAPY; DRUG TOLERANCE; LIVER; PATHOLOGY; PYRIMIDINES; SULFONAMIDES; TOLBUTAMIDE; TOXICOLOGIC REPORT
ZUR THERAPIE DES DIABETES MELLITUS MIT 2-BENZOLSULFONAMIDO-5(BETA-METHOXYAETHOXY)-PYRIMIDIN (GLYCODIAZIN). ERFAHRUNG AN 160 DIABETIKERN.